Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

about

Cardio-oncology: protecting the heart from curative breast cancer treatment Protecting the heart in cancer therapy

P2860

Q57108766-CBB385FD-2A59-4BB3-9BBC-7797B3AE09CC Q57821006-73C5FF67-8BC3-4A89-9954-C722EC7A7D0B

P2860

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

Item

http://www.wikidata.org/entity/Q40132680

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

@en

type

Item

label

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

@en

prefLabel

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

@en

P1476

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

@en

P2093

Amy Clark

http://www.w3.org/2001/XMLSchema#string

Angela Bradbury

http://www.w3.org/2001/XMLSchema#string

Angela DeMichele

http://www.w3.org/2001/XMLSchema#string

Bonnie Ky

http://www.w3.org/2001/XMLSchema#string

Brian S Finkelman

http://www.w3.org/2001/XMLSchema#string

Hari Narayan

http://www.w3.org/2001/XMLSchema#string

Jennifer Matro

http://www.w3.org/2001/XMLSchema#string

Joseph R Carver

http://www.w3.org/2001/XMLSchema#string

Kevin Fox

http://www.w3.org/2001/XMLSchema#string

Le Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelium-dependent contractions and endothelial dysfunction in human hypertension

Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.

Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.

Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice.

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.

Asymmetric dimethylarginine, race, and mortality in hemodialysis patients.

Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.

P304

152-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2017.05.019

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan M Domchek

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28683962

http://www.w3.org/2001/XMLSchema#string

P932

5665653

http://www.w3.org/2001/XMLSchema#string

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

about

P2860

P2860

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932